Raymond James Financial Services Advisors’s CorMedix CRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$650K Sell
80,499
-2,446
-3% -$19.8K ﹤0.01% 2431
2024
Q2
$359K Sell
82,945
-350
-0.4% -$1.52K ﹤0.01% 2761
2024
Q1
$353K Buy
83,295
+1,461
+2% +$6.2K ﹤0.01% 2742
2023
Q4
$308K Buy
81,834
+10,362
+14% +$39K ﹤0.01% 2717
2023
Q3
$264K Sell
71,472
-780
-1% -$2.89K ﹤0.01% 2736
2023
Q2
$286K Sell
72,252
-50
-0.1% -$198 ﹤0.01% 2682
2023
Q1
$299K Sell
72,302
-505
-0.7% -$2.09K ﹤0.01% 2641
2022
Q4
$307K Buy
72,807
+24,400
+50% +$103K ﹤0.01% 2565
2022
Q3
$137K Buy
48,407
+6,037
+14% +$17.1K ﹤0.01% 2937
2022
Q2
$170K Buy
42,370
+3,355
+9% +$13.5K ﹤0.01% 2889
2022
Q1
$214K Sell
39,015
-3,015
-7% -$16.5K ﹤0.01% 2914
2021
Q4
$191K Sell
42,030
-2,182
-5% -$9.92K ﹤0.01% 2979
2021
Q3
$206K Buy
44,212
+695
+2% +$3.24K ﹤0.01% 2959
2021
Q2
$299K Buy
43,517
+1,261
+3% +$8.66K ﹤0.01% 2718
2021
Q1
$422K Buy
42,256
+16,986
+67% +$170K ﹤0.01% 2402
2020
Q4
$188K Sell
25,270
-60
-0.2% -$446 ﹤0.01% 2731
2020
Q3
$153K Buy
25,330
+580
+2% +$3.5K ﹤0.01% 2596
2020
Q2
$156K Buy
24,750
+750
+3% +$4.73K ﹤0.01% 2539
2020
Q1
$86K Buy
24,000
+3,815
+19% +$13.7K ﹤0.01% 2242
2019
Q4
$147K Buy
20,185
+421
+2% +$3.07K ﹤0.01% 2641
2019
Q3
$126K Buy
19,764
+1,464
+8% +$9.33K ﹤0.01% 2599
2019
Q2
$164K Buy
18,300
+6,539
+56% +$58.6K ﹤0.01% 2585
2019
Q1
$111K Buy
+11,761
New +$111K ﹤0.01% 2622
2017
Q2
Sell
-2,608
Closed -$21K 2489
2017
Q1
$21K Sell
2,608
-800
-23% -$6.44K ﹤0.01% 2345
2016
Q4
$26K Sell
3,408
-90
-3% -$687 ﹤0.01% 2251
2016
Q3
$44K Sell
3,498
-4,818
-58% -$60.6K ﹤0.01% 2198
2016
Q2
$83K Buy
8,316
+1,190
+17% +$11.9K ﹤0.01% 2113
2016
Q1
$94K Buy
+7,126
New +$94K ﹤0.01% 1894